These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9574466)

  • 1. Patterns of dietary intake and serum lipids interact with proteinuria as risk factors for progression of chronic renal failure.
    Boaz M; Biro A; Katzir Z; Smetana S
    Ren Fail; 1998 Mar; 20(2):383-90. PubMed ID: 9574466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Northern Italian Cooperative Study Group.
    Locatelli F; Marcelli D; Comelli M; Alberti D; Graziani G; Buccianti G; Redaelli B; Giangrande A
    Nephrol Dial Transplant; 1996 Mar; 11(3):461-7. PubMed ID: 8710157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid and apolipoprotein patterns during erythropoietin therapy: roles of erythropoietin, route of administration, and diet.
    Allegra V; Martimbianco L; Vasile A
    Nephrol Dial Transplant; 1997 May; 12(5):924-32. PubMed ID: 9175044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline serum lipids and renal function in chronic kidney disease patients entering the LORD trial.
    Fassett RG; Ball MJ; Robertson IK; Geraghty DP; Coombes JS
    Int J Clin Pharmacol Ther; 2006 Nov; 44(11):580-8. PubMed ID: 17176625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal pathology and proteinuria determine progression in untreated mild/moderate chronic renal failure.
    Williams PS; Fass G; Bone JM
    Q J Med; 1988 Apr; 67(252):343-54. PubMed ID: 3205906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of renal failure in chronic primary glomerular diseases.
    Gonzalo A; Gallego A; Rivera M; Gallego N; Ortuño J
    Nephron; 1994; 68(1):32-7. PubMed ID: 7991038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rise in serum albumin and creatinine in the first half year on hemodialysis.
    Goldwasser P; Kaldas AI; Barth RH
    Kidney Int; 1999 Dec; 56(6):2260-8. PubMed ID: 10594804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of progression of chronic renal failure--using reciprocal of serum creatinine.
    Muthusethupathi MA; Kumar SS; Sekaran L
    J Assoc Physicians India; 1989 Mar; 37(3):213-6. PubMed ID: 2768164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between women and men with chronic renal disease.
    Coggins CH; Breyer Lewis J; Caggiula AW; Castaldo LS; Klahr S; Wang SR
    Nephrol Dial Transplant; 1998 Jun; 13(6):1430-7. PubMed ID: 9641172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency.
    Samuelsson O; Mulec H; Knight-Gibson C; Attman PO; Kron B; Larsson R; Weiss L; Wedel H; Alaupovic P
    Nephrol Dial Transplant; 1997 Sep; 12(9):1908-15. PubMed ID: 9306342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidaemia and the progression of renal disease in chronic renal failure patients.
    Massy ZA; Nguyen Khoa T; Lacour B; Descamps-Latscha B; Man NK; Jungers P
    Nephrol Dial Transplant; 1999 Oct; 14(10):2392-7. PubMed ID: 10528663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids.
    Bergesio F; Monzani G; Ciuti R; Cirami C; Martinelli F; Salvadori M; Tosi PL
    Nephron; 2001 Feb; 87(2):127-33. PubMed ID: 11244306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis.
    Yan B; Su X; Xu B; Qiao X; Wang L
    PLoS One; 2018; 13(11):e0206134. PubMed ID: 30403710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting progression of renal failure in patients with type 2 diabetes.
    Ueda H; Ishimura E; Shoji T; Emoto M; Morioka T; Matsumoto N; Fukumoto S; Miki T; Inaba M; Nishizawa Y
    Diabetes Care; 2003 May; 26(5):1530-4. PubMed ID: 12716817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dyslipidemia in the progression of chronic renal disease.
    Cappelli P; Di Liberato L; Albertazzi A
    Ren Fail; 1998 Mar; 20(2):391-7. PubMed ID: 9574467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure.
    Maschio G; Oldrizzi L; Tessitore N; D'Angelo A; Valvo E; Lupo A; Loschiavo C; Fabris A; Gammaro L; Rugiu C
    Kidney Int Suppl; 1983 Dec; 16():S273-7. PubMed ID: 6588264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of dietary protein and phosphate restriction to retard the rate of progression of chronic renal failure: a prospective, randomized, controlled trial.
    Williams PS; Stevens ME; Fass G; Irons L; Bone JM
    Q J Med; 1991 Oct; 81(294):837-55. PubMed ID: 1801057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.
    Mora-Macía J; Cases A; Calero F; Barceló P
    Nephrol Dial Transplant; 2001; 16 Suppl 1():82-4. PubMed ID: 11369829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of low-protein diet supplemented with ketoacids in patients with chronic renal failure].
    Molnár M; Szekeresné Izsák M; Nagy J; Figler M
    Orv Hetil; 2009 Feb; 150(5):217-24. PubMed ID: 19158020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.